Testicular Cancer - Discoveries and Updates

被引:258
作者
Hanna, Nasser H. [1 ]
Einhorn, Lawrence H. [1 ]
机构
[1] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
关键词
GERM-CELL TUMORS; HIGH-DOSE CHEMOTHERAPY; RANDOMIZED PHASE-III; GENOME-WIDE ASSOCIATION; LYMPH-NODE DISSECTION; LONG-TERM SURVIVORS; CARCINOMA IN-SITU; COMBINATION CHEMOTHERAPY; CISPLATIN CHEMOTHERAPY; SALVAGE TREATMENT;
D O I
10.1056/NEJMra1407550
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:2005 / 2016
页数:12
相关论文
共 73 条
[1]   Sequelae of Treatment in Long-term Survivors of Testis Cancer [J].
Abouassaly, Robert ;
Fossa, Sophie D. ;
Giwercman, Aleksander ;
Kollmannsberger, Christian ;
Motzer, Robert J. ;
Schmoll, Hans-Joachim ;
Sternberg, Cora N. .
EUROPEAN UROLOGY, 2011, 60 (03) :516-526
[2]   Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German testicular cancer study group [J].
Albers, Peter ;
Siener, Roswitha ;
Krege, Susanne ;
Schmelz, Hans-Uwe ;
Dieckmann, Klaus-Peter ;
Heidenreich, Axel ;
Kwasny, Peter ;
Pechoel, Maik ;
Lehmann, Jan ;
Kliesch, Sabine ;
Koehrmann, Kai-Uwe ;
Fimmers, Rolf ;
Weissbach, Lothar ;
Loy, Volker ;
Wittekind, Christian ;
Hartmann, Michael .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (18) :2966-2972
[3]   Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling [J].
Almstrup, K ;
Hoei-Hansen, CE ;
Wirkner, U ;
Blake, J ;
Schwager, C ;
Ansorge, W ;
Nielsen, JE ;
Skakkebæk, NE ;
Meyts, ERD ;
Leffers, H .
CANCER RESEARCH, 2004, 64 (14) :4736-4743
[4]  
[Anonymous], J CLIN ONCOL S
[5]  
[Anonymous], J CLIN ONCOL S
[6]  
[Anonymous], J CLIN ONCOL S
[7]   A RANDOMIZED TRIAL OF ETOPOSIDE + CISPLATIN VERSUS VINBLASTINE + BLEOMYCIN + CISPLATIN + CYCLOPHOSPHAMIDE + DACTINOMYCIN IN PATIENTS WITH GOOD-PROGNOSIS GERM-CELL TUMORS [J].
BOSL, GJ ;
GELLER, NL ;
BAJORIN, D ;
LEITNER, SP ;
YAGODA, A ;
GOLBEY, RB ;
SCHER, H ;
VOGELZANG, NJ ;
AUMAN, J ;
CAREY, R ;
FAIR, WR ;
HERR, H ;
MORSE, M ;
SOGANI, P ;
WHITMORE, W .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (08) :1231-1238
[8]   Molecular biomarkers as potential targets for therapeutic strategies in human testicular germ cell tumors: An overview [J].
Chieffi, Paolo ;
Chieffi, Sergio .
JOURNAL OF CELLULAR PHYSIOLOGY, 2013, 228 (08) :1641-1646
[9]   Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors:: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T9313P) [J].
Culine, S. ;
Kerbrat, P. ;
Kramar, A. ;
Theodore, C. ;
ChevreauU, C. ;
Geoffrois, L. ;
Bui, N. B. ;
Peny, J. ;
Caty, A. ;
Delva, R. ;
Biron, P. ;
Fizazi, K. ;
Bouzy, J. ;
Droz, J. P. .
ANNALS OF ONCOLOGY, 2007, 18 (05) :917-924
[10]   A genome-wide association study of men with symptoms of testicular dysgenesis syndrome and its network biology interpretation [J].
Dalgaard, Marlene D. ;
Weinhold, Nils ;
Edsgard, Daniel ;
Silver, Jeremy D. ;
Pers, Tune H. ;
Nielsen, John E. ;
Jorgensen, Niels ;
Juul, Anders ;
Gerds, Thomas A. ;
Giwercman, Aleksander ;
Giwercman, Yvonne L. ;
Cohn-Cedermark, Gabriella ;
Virtanen, Helena E. ;
Toppari, Jorma ;
Daugaard, Gedske ;
Jensen, Thomas S. ;
Brunak, Soren ;
Rajpert-De Meyts, Ewa ;
Skakkebk, Niels E. ;
Leffers, Henrik ;
Gupta, Ramneek .
JOURNAL OF MEDICAL GENETICS, 2012, 49 (01) :58-65